Skip to main content

Table 2 Comparison of changes in clinical parameters between abstainers and continued smokers

From: Effects of smoking cessation on endothelial function as assessed by flow-mediated total dilation

 

Abstainers (n = 85)

Continued smokers (n = 33)

p-valuea

Baseline

Week 20

Change

Baseline

Week 20

Change

Sex, % males

69.4% (n = 59)

  

81.8% (n = 27)

   

Age, years

59 ± 12

  

58 ± 11

   

BMI, kg/m2

23.7 ± 3.7

24.4 ± 3.8

0.7 ± 0.9

23.8 ± 3.8

24.3 ± 4.1

0.5 ± 0.8

0.157

Brinkman index

817 ± 410

  

808 ± 378

   

Cigarettes per day

22 ± 10

  

24 ± 10

   

CO concentration, ppm

14.3 ± 9.7

1.9 ± 0.8

-12.5 ± 9.8

18.2 ± 11.7

7.6 ± 5.0

-10.8 ± 11.8

0.520

Hypertension

34.1% (n = 29)

  

45.4% (n = 15)

   

SBP, mmHg

117.7 ± 19.1

121.7 ± 17.1

4.0 ± 11.5

122.5 ± 13.7

121.8 ± 15.8

-0.7 ± 11.2

0.048*

DBP, mmHg

74.6 ± 10.6

77.0 ± 9.7

2.4 ± 7.6

79.1 ± 7.8

79.2 ± 9.2

0.2 ± 7.7

0.161

HR, beats/min

65.2 ± 10.9

66.5 ± 10.3

0.7 ± 7.6

68.2 ± 13.8

67.2 ± 13.5

-0.3 ± 10.5

0.576

Diabetes mellitus

23.5% (n = 20)

  

24.2% (n = 8)

   

HbA1c, %

6.0 ± 0.9

6.2 ± 1.1

0.1 ± 0.6

6.0 ± 0.9

6.0 ± 1.3

0.0 ± 0.5

0.139

Fasting glucose, mg/dl

100.7 ± 22.9

108.7 ± 33.5

7.9 ± 19.6

100.8 ± 12.5

103.3 ± 24.0

2.5 ± 17.8

0.180

Dyslipidemia

71.8% (n = 61)

  

60.6% (n = 20)

   

HDL-C, mg/dl

50.9 ± 15.7

54.0 ± 17.8

3.0 ± 9.6

49.1 ± 10.8

46.8 ± 11.3

-2.3 ± 9.1

0.007**

LDL-C, mg/dl

116.0 ± 34.5

118.5 ± 38.5

2.3 ± 27.7

110.7 ± 28.6

111.1 ± 34.9

0.4 ± 27.1

0.741

Triglycerides, mg/dl

153.0 ± 98.0

170.7 ± 206.9

17.6 ± 171.0

147.1 ± 103.7

167.1 ± 94.1

20.0 ± 119.1

0.941

eGFR, ml/min/1.73 m2

75.5 ± 21.1

74.6 ± 16.4

-1.0 ± 16.1

77.1 ± 17.0

75.0 ± 25.8

-2.1 ± 14.8

0.721

Dbase, mm

4.04 ± 0.67

4.12 ± 0.65

0.08 ± 0.36

4.27 ± 0.66

4.29 ± 0.62

0.02 ± 0.43

0.459

L-FMC

35.3% (n = 30)

27.1% (n = 23)

 

30.3% (n = 10)

24.2% (n = 8)

  

%L-FMC, %

-1.15 ± 1.90

-0.88 ± 1.71

0.27 ± 2.19

-1.20 ± 2.24

-0.48 ± 1.11

0.76 ± 2.31

0.292

%FMD, %

3.93 ± 1.91

4.89 ± 2.22

0.95 ± 2.28

4.35 ± 2.62

4.38 ± 2.91

0.06 ± 2.81

0.079

%FMTD, %

5.08 ± 2.36

5.77 ± 2.91

0.69 ± 2.59

5.55 ± 2.96

4.86 ± 3.11

-0.70 ± 2.03

0.007**

baIMT, mm

0.30 ± 0.08

0.31 ± 0.08

0.00 ± 0.06

0.32 ± 0.06

0.32 ± 0.06

0.00 ± 0.06

0.824

  1. BMI = body mass index; CO = carbon monoxide; SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart rate; HbA1c = glycosylated hemoglobin; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; eGFR = estimated glomerular giltration rate; Dbase = resting baseline lumen diameter; L-FMC = low-flow-mediated constriction; FMD = flow-mediated dilation; FMTD = flow-mediated total dilation; baIMT = brachial artery intima-media thickness
  2. *p < 0.05, **p < 0.01
  3. aChange, abstainers vs. continued smokers